Health and Wellness

Obamacare Insurer Oscar Health Sees 2026 ‘Return To Profitability’

Oscar Health Predicts Return to Profitability Despite $137 Million Third Quarter Loss Oscar Health Thursday reported a $137 million third quarter loss but predicts “a return to profitability” as the

Your Trusted Source for Accurate and Timely Updates!

Our commitment to accuracy, impartiality, and delivering breaking news as it happens has earned us the trust of a vast audience. Stay ahead with real-time updates on the latest events, trends.

Lasted Health and Wellness

Independent doctor advocacy group IndeMed launches

A new health care advocacy group called IndeMed is set to launch on Wednesday, representing the dwindling number of independent

December CDC Vaccine Advisory Committee Agenda To Focus On Hepatitis B And Childhood Vaccine Schedule

The upcoming CDC’s vaccine advisory committee meeting, known as the Advisory Committee on Immunization Practices (ACIP), is set to take

AI To Guide Use Of Prior Authorization In Medicare Through Demo Project

The Center for Medicare and Medicaid Innovation recently announced the launch of the Wasteful and Inappropriate Service Reduction (WISeR) Model

The Therapies Poised To Transform Medicine

Gene therapy is at the forefront of modern medicine, bringing about revolutionary changes that have the potential to eradicate inherited

Trump May Have A Health Plan But Fellow Republicans Balk At Part Of It

President Trump may have a plan to fix Obamacare, including an extension of premium subsidies and reform of the program.

ACIP hepatitis B review: Vaccine experts say they’re being excluded

The federal government's vaccine advisory panel is set to evaluate the hepatitis B vaccine this week, but there are concerns

WHO Formally Recognizes Cannabis Use Syndrome, Spiking 650% Since 2016

The World Health Organization (WHO) has recently made a significant update by including Cannabinoid Hyperemesis Syndrome (CHS) in its diagnostic

Top drug regulator Richard Pazdur set to leave the FDA

Top drug regulator Richard Pazdur has announced his retirement from the Food and Drug Administration (FDA), adding to the ongoing